Enzyme-Inducing Antiepileptic Drugs and the Risk of Vitamin D Deficiency
6 minutes read time Epilepsy is a chronic neurological disorder characterised by an enduring predisposition to generate epileptic seizures. It is...
Understanding Hypoglycaemia Risks in Diabetes from Polypharmacy Practices
6 minutes read time Hypoglycaemia, a condition in which blood glucose concentration falls below 70 mg/dL (3.9 mmol/L) [1], remains a clinically...
From Errors to Efficiency: Why Hospitals Can’t Afford to Skip Medication Safety
5 minutes read time Medication safety underpins every phase of patient treatment. Yet without modern digital infrastructure, hospitals continue to...
Clinically Significant Drug Interactions with Grapefruit: What Prescribers Need to Know
4 minutes read time Grapefruit is often praised for its nutritional value, but for patients on certain medications, this seemingly harmless fruit...
Polypharmacy and Hyperglycaemia Risk in Patients with Diabetes
Polypharmacy in type 2 diabetes (T2DM) is common and linked to poorer glycaemic outcomes. How can MIMS CDS support clinicians to improve patient safety?
Implementing Clinical Decision Support System (CDSS): A Path to Success
5 minutes read time CDSS (Clinical Decision Support System) have become indispensable tools in today’s evolving healthcare landscape, helping...